Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Return on Capital Employed (2019 - 2025)

Neurogene's Return on Capital Employed history spans 5 years, with the latest figure at 0.38% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 3.0% year-over-year to 0.38%; the TTM value through Dec 2025 reached 0.38%, down 3.0%, while the annual FY2025 figure was 0.35%, 4.0% down from the prior year.
  • Return on Capital Employed reached 0.38% in Q4 2025 per NGNE's latest filing, down from 0.35% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.22% in Q1 2023 to a low of 0.5% in Q3 2023.
  • Average Return on Capital Employed over 3 years is 0.37%, with a median of 0.37% recorded in 2024.
  • Peak YoY movement for Return on Capital Employed: fell -9bps in 2024, then grew 14bps in 2025.
  • A 3-year view of Return on Capital Employed shows it stood at 0.42% in 2023, then rose by 16bps to 0.35% in 2024, then fell by -8bps to 0.38% in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Return on Capital Employed are 0.38% (Q4 2025), 0.35% (Q3 2025), and 0.33% (Q2 2025).